Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Harbeck, N 
Titel:
Never too late: reducing late breast cancer relapse risk. 
Abstract:
BACKGROUND: Breast cancer is the most common cancer diagnosed in Europe, with an estimated 429,900 new cases diagnosed in 2006. For over 20 years, tamoxifen was the standard adjuvant (postoperative) endocrine treatment for hormone receptor-positive (i.e., endocrine-responsive) early breast cancer. Yet, even after the first 5 years, patients with hormone receptor-positive tumours are at risk of relapse. Particularly in endocrine-responsive disease, most instances of relapse and breast cancer mort...    »
 
Zeitschriftentitel:
Curr Med Res Opin 
Jahr:
2008 
Band / Volume:
24 
Heft / Issue:
12 
Seitenangaben Beitrag:
3295-305 
Sprache:
eng 
Print-ISSN:
0300-7995 
TUM Einrichtung:
Frauenklinik und Poliklinik